Clinical Trial Details
EORTC-21011
Back to Clinical Trials Database
A randomised, open-label phase III trial to evaluate the efficacy and safety of Bexarotene (Targretin TM) capsules combined with PUVA, compared to PUVA treatment alone in patients with Mycosis Fungoides.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 20-Jan-2003 Date Step1 close: 31-May-2010 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 140 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00056056 |
| NCT number | NCT00056056 |
| EudraCT | 2004-003701-24 |
